Could a cheap old drug beat blood cancer? lab study launches

NCT ID NCT04234022

Recruiting now Knowledge-focused Sponsor: The Royal Wolverhampton Hospitals NHS Trust Source: ClinicalTrials.gov ↗

First seen Jan 19, 2026 · Last updated Jun 11, 2026 · Updated 30 times

Summary

This study takes blood or bone marrow samples from 70 adults with multiple myeloma or acute leukemia to test a drug called Imuthiol (Zn-DDC) in the lab. Researchers want to see if Imuthiol, alone or with other drugs, can kill cancer stem cells. This is not a treatment study—it's a first step to see if the drug is worth testing in future human trials.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

The Royal Wolverhampton NHS Trust
RECRUITING

Wolverhampton, WV10 0QP, United Kingdom

Contact Email: •••••@•••••

Contact Email: •••••@•••••

Contact

Conditions

The condition(s) this trial relates to.

plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE MYELOMA